関連する実験動画
Updated: Jun 13, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
子どもの肥満 子どもの肥満
Joan C Han1, Debbie A Lawlor, Sue Y S Kimm
1Unit on Growth and Obesity, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, DHHS, Bethesda, MD, USA.
Lancet (London, England)
|May 11, 2010
まとめ
幼児の肥満は,2型糖尿病に関連した流行病である. 現在の予防と治療戦略は,より良い結果のためにカロリー摂取と身体活動に焦点を当てて再評価する必要があります.
科学分野:
- 小児科は小児科です.
- 公衆衛生は公衆衛生である.
- エンドクリノロジー エンドクリノロジー
背景:
- 子どもの肥満の発生率は,過去30年間で世界中で急増しています.
- この流行は,子どもにおける2型糖尿病のような疾患の発生率の増加と関連しています.
- 稀な肥満症候群はよりよく理解されているが,一般的な小児肥満管理には限られた洞察を提供している.
研究 の 目的:
- 子どものための現在のカロリー摂取量と身体活動に関する推奨事項の再評価の必要性を強調する.
- 効果的な予防と治療戦略のための高品質で長期的な研究の必要性を強調する.
- エネルギー支出の増加とエネルギー消費量の減少の両方に対する継続的な努力の重要性を強調する.
主な方法:
- 食欲制御の遺伝学と生理学の現在の理解のレビュー.
- 人口レベルの静止生活様式とそのエネルギーバランスへの影響の分析.
- 既存の研究品質の評価と将来の多センター試験のニーズの特定.
主要な成果:
- 希少な肥満症候群は,小児肥満の予防や逆転に限られた教訓を提供している.
- 現在のカロリー推奨値は",エネルギーギャップ"のために不十分かもしれません.
- 証拠は,子供の肥満率の急速な増加が安定する可能性を示唆しています.
結論:
- カロリー摂取量と身体活動に関する人口レベルの推奨事項は,緊急に再評価する必要がある.
- 高品質で長期にわたる多センター試験は,予防と治療の進歩に不可欠です.
- エネルギー支出を増やし,摂取量を減らすための継続的な努力は,肥満の傾向の継続的な監視とともに,不可欠です.
関連する概念動画
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

